Overview

Antithrombotic Effects of Ticagrelor Versus Clopidogrel

Status:
Completed
Trial end date:
2013-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether treatment with ticagrelor (plus aspirin and bivalirudin) is more effective than treatment with clopidogrel (plus aspirin and bivalirudin).
Phase:
Phase 4
Details
Lead Sponsor:
Juan J Badimon
Collaborator:
AstraZeneca
Treatments:
Aspirin
Bivalirudin
Clopidogrel
Hirudins
Ticagrelor
Ticlopidine